Article Text

Download PDFPDF
Detection of acute HIV infections among sexually transmitted disease clinic patients: a practice in Guangxi Zhuang Autonomous Region, China
  1. Y-P Yin1,
  2. X-S Chen1,
  3. H-C Wang1,
  4. M-Q Shi1,
  5. W-H Wei1,
  6. B-Y Zhu2,
  7. Y-H Yu1,
  8. J D Tucker3,
  9. M S Cohen4
  1. 1
    National Center for STD Control, Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Dermatology, Nanjing, China
  2. 2
    Guangxi Autonomous Region Institute of Dermatology, Nanning, China
  3. 3
    Massachusetts General Hospital, Boston, USA
  4. 4
    School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA
  1. Dr Xiang-Sheng Chen, National Center for STD Control, 12 Jiangwangmiao Street, Nanjing 210042, China; chenxs{at}


Detection of people with acute HIV infection (AHI) affords an important opportunity for early HIV treatment and prevention. HIV RNA reverse transcriptase-polymerase chain reaction (RT-PCR) testing with two-stage pooling scheme was used to detect the AHI in specimens collected from sexually transmitted disease (STD) clinic patients in Guangxi, China. A total of 246 HIV RNA tests were required to screen 11 395 samples negative for conventional enzyme immunoassay (EIA) and Western blot assays, and five AHI cases (0.04%, 95%CI 0.02% to 0.10%) with a high viral load (median of 265 677 copies per ml) were detected. The total expenditure for RT-PCR testing reflected an added cost of $2.9 per specimen screened and $6575 per additional case of AHI identified among the study population. This study supports the feasibility of pooled RNA testing in addition to detection of HIV infections among patients at STD clinics in China, but the cost effectiveness should be carefully considered.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Ethics approval: This study was approved by the Protection of the Rights of Human Subjects Institutional Review Board (IRB) at the UNC at Chapel Hill and the Medical Ethics Committee at the National Center for STD Control (NCSTD).

  • Contributors: XSC and MSC were principal investigators who were responsible for the study design, data analysis and manuscript preparation. YPY was responsible for study design and laboratory implementation. JDT helped with study design and manuscript preparation. HCW and BYZ were responsible for field coordination. MQS, WHW and YHY were the laboratory based senior technicians who were responsible for laboratory testing.